Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum

被引:3
|
作者
Idowu, Oladipo S. [1 ]
Craigen, Jenny L. [2 ]
Veal, Gareth J. [1 ]
Jamieson, David [1 ]
机构
[1] Newcastle Univ, Newcastle Univ Ctr Canc, Newcastle Upon Tyne NE2 4HH, England
[2] Canc Res UK Ctr Drug Dev, London E20 1JQ, England
关键词
assay validation; cancer; ELISA; HER3; pharmacokinetics; RECEPTOR HETERODIMERIZATION; ERBB3; EXPRESSION; GROWTH; CANCER; HER3;
D O I
10.4155/bio-2022-0141
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: HMBD-001 is an IgG1 humanized monoclonal antibody specifically targeting HER3, a receptor highly expressed on cancer cells in certain tumors. A bioanalytical method was required to quantify HMBD-001 in human serum, with high selectivity and without interference from HER3. Methods and results: A bridging ELISA using an anti-idiotypic monoclonal capture and detection was developed and validated for quantitative measurement of HMBD-001 in human serum. The assay is sensitive, with a lower limit of quantification of 250 ng/ml, has a broad dynamic range of 250-7000 ng/ml HMBD-001, and exhibits excellent precision and overall accuracy. Conclusion: We have developed and validated a sensitive and selective method for measuring HMBD-001 in human serum. This assay is now being used in a clinical trial setting.
引用
收藏
页码:1241 / 1249
页数:9
相关论文
共 50 条
  • [21] Enzyme linked immunosorbent assay development and full validation for the quantification of the antibody conjugated fraction of an antiFAP ADC in human serum
    Blasco, L.
    Garcia, S.
    Alcaraz, E.
    Woodworth, A.
    Alonso, R.
    Leal, N.
    CLINICAL CHEMISTRY, 2024, 70 : I248 - I248
  • [22] Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum
    Paglia, G.
    D'Apolito, O.
    Garofalo, D.
    Scarano, C.
    Corso, G.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 860 (02): : 153 - 159
  • [23] Validation of anti-idiotypic bridging ELISA to quantitate TRX4 (anti-human CD3) mab levels in human serum
    Carmody, Francis
    Slavonic, Michael
    O'Shea, Adam
    Paglia, Michael
    Gulati, Reema
    Li, Sharon
    Dunn, William
    Rosenzweig, Michale
    CLINICAL IMMUNOLOGY, 2007, 123 : S20 - S21
  • [24] Human pharmacokinetic (PK) characterization of the novel dual-action anti-HER3/EGFR antibody MEHD7945A (MEHD) in patients with refractory/recurrent epithelial tumors
    Hidalgo, Manuel
    Calles, Antonio
    Juric, Dejan
    Dienstmann, Rodrigo
    Perez, Desamparados Roda
    Messersmith, Wells A.
    Blumenschein, George R.
    Baselga, Jose
    Tabernero, Josep
    Cervantes-Ruiperez, Andres
    Jimeno, Antonio
    Jin, Denise
    Bai, Shuang
    Gurevich, Pavel
    Nijem, Ihsan
    Holden, Scott N.
    Davis, John D.
    Halpern, Wendy
    Pirzkall, Andrea
    Xin, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFα antibody in human serum
    Horninger, D
    Eirikis, E
    Pendley, C
    Giles-Komar, J
    Davis, HM
    Miller, BE
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 38 (04) : 703 - 708
  • [26] Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte
    Campi, Beatrice
    Frascarelli, Sabina
    Pietri, Elisabetta
    Massa, Ilaria
    Donati, Caterina
    Bozic, Roberto
    Bertelloni, Silvano
    Paolicchi, Aldo
    Zucchi, Riccardo
    Saba, Alessandro
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2018, 410 (02) : 407 - 416
  • [27] Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte
    Beatrice Campi
    Sabina Frascarelli
    Elisabetta Pietri
    Ilaria Massa
    Caterina Donati
    Roberto Bozic
    Silvano Bertelloni
    Aldo Paolicchi
    Riccardo Zucchi
    Alessandro Saba
    Analytical and Bioanalytical Chemistry, 2018, 410 : 407 - 416
  • [28] Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum
    Chowdhury, F.
    Tutt, A. L.
    Chan, C.
    Glennie, M.
    Johnson, P. W.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 363 (01) : 1 - 8
  • [29] Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum
    Albrethsen, Jakob
    Frederiksen, Hanne
    Andersson, Anna-Maria
    Anand-Ivell, Ravinder
    Nordkap, Loa
    Bang, Anne Kirstine
    Jorgensen, Niels
    Juul, Anders
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (11) : 1913 - 1920
  • [30] Development and validation of a simple HPLC-MS/MS method for the quantification of methylmalonic acid in human serum without a derivatization step
    Hofmann, Sabrina
    Gebauer, Julian
    Krnac, Dusan
    Prantz, Anja
    Reiffova, Katarina
    Rolinski, Boris
    Serbin, Rastislav
    BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (08)